Ignite Creation Date:
2024-05-06 @ 7:36 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06075420
Status:
RECRUITING
Last Update Posted:
2023-10-18
First Post:
2023-10-04
Brief Title:
Evaluating Efficacy and Safety of Short Duration of DAPT After Genoss DES Stent Implantation in Patients
Sponsor:
Genoss Co Ltd
Organization:
Genoss Co Ltd
Study Overview
Official Title:
Prospective Multicenter Observational Study for Evaluating Efficacy and Safety of Short Duration of Dual Antiplatelet Therapy After Genoss DES Sirolimus-eluting Stent Implantation in Patients With Coronary Artery Disease
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DAPTShort
Brief Summary:
The investigators aimed to evaluate the safety and effectiveness of short-term DAPT 3 months for SCAD 6 months for ACS after PCI with Genoss DES in patients with coronary artery disease
Detailed Description:
This study is a sponsor-initiated clinical trial SIT that enrolls patients with coronary artery disease who have undergone percutaneous coronary intervention using the GENOSS DES stent as research subjects collects data on the patients clinical and surgical procedures and reports on clinical events The investigators will track the outbreak
This study is a prospective multicenter registration observational study that will enroll patients with coronary artery disease who underwent percutaneous coronary intervention with GENOSS DES at a total of five institutions
This study is a registered observation study and does not separately calculate the number of subjects but plans to recruit a total of 1000 subjects during the study period
This study is a prospective multicenter registration observational study that will enroll patients with coronary artery disease who underwent percutaneous coronary intervention with GENOSS DES at a total of five institutions
This study is a registered observation study and does not separately calculate the number of subjects but plans to recruit a total of 1000 subjects during the study period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None